Receding horizon control of HIV

Optimal Control Applications and Methods

Volumn 32, Issue 6, 2011, Pages 681-699

  David, John ^a,b   Tran, Hien ^b   Banks, H T ^b  

^a 931 College Mall   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

extended Kalman filter; HIV model; Receding Horizon Control; state estimator

Indexed keywords

CLINICAL CONDITIONS; HIV MODELS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INCOMPLETE DATA; MODEL SPECIFICATIONS; RANDOM SIMULATION; RECEDING HORIZON CONTROL; STABLE EQUILIBRIUM; STATE ESTIMATORS; STOCHASTIC ESTIMATION; TREATMENT INTERRUPTION; VIRAL LOAD;

DRUG THERAPY; EXTENDED KALMAN FILTERS; VIRUSES;

DISEASES;

EID: 82055172633     PISSN: 01432087     EISSN: 10991514     Source Type: Journal    
DOI: 10.1002/oca.969     Document Type: Article

References (30)

1. Kirschner D, Lenhart S, Serbin S,. Optimal control of the chemotherapy of HIV. Journal of Mathematical Biology 1997; 35: 775-792.
2. Joshi HR,. Optimal control of an HIV immunology model. Optimal Control Applications and Methods 2002; 23: 199-213. (Pubitemid 35010217)
3. Adams BM, Banks HT, Kwon H-D, Tran HT,. Dynamic multidrug therapies for HIV: optimal and STI control approaches. Mathematical Biosciences and Engineering 2004; 1 (2): 223-241.
4. Culshaw RV, Ruan S, Spiteri RJ,. Optimal HIV treatment by maximising immune response. Journal of Mathematical Biology 2004; 48: 545-562. (Pubitemid 40882743)
5. Fister KR, Lenhart S, McNally JS,. Optimizing chemotherapy in an HIV model. Electronic Journal of Differential Equations 1998; 1998 (32): 1-12. (Pubitemid 38994892)
6. Garira W, Musekwa SD, Shiri T,. Optimal control of combined therapy in a single strain HIV-1 model. Electronic Journal of Differential Equations 2005; 2005 (52): 1-22.
7. Perelson AS, Nelson PW,. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Review 1999; 41 (1): 3-44. (Pubitemid 129723746)
8. Banks HT, Kwon H-D, Toivanen JA, Tran H,. An SDRE base estimator approach for HIV feedback control. Optimal Control Applications and Methods 2006; 27 (2): 93-121.
9. Mayne DQ, Rawlings JB, Rao CV, Scokaert POM,. Constrained model predictive control: stability and optimality. Automatica 2000; 36: 789-814. (Pubitemid 30587683)
10. Qin S, Badgewell T,. An overview of industrial model predictive control technology. Chemical Process Control 1997; 93 (316): 232-256.
11. Shim H, Han SJ, Chung CC, Nam SW, Seo JH,. Optimal scheduling of drug treatment for HIV infection: continuous dose control and receding horizon control. International Journal of Control, Automation and Systems 2003; 1 (3): 401-407.
12. Zurakowski R, Messina MJ, Tuna SE, Teel AR,. HIV treatment scheduling via robust nonlinear model predictive control. Proceedings of the Fifth Asian Control Conference, Melbourne, Australia, 2004.
13. Zurakowski R, Teel AR,. A model predictive control based scheduling method for HIV therapy. Journal of Theoretical Biology 2006; 238 (2): 368-382. (Pubitemid 41828437)
14. Zurakowski R,. An output-feedback MPC-based scheduling method for enhancing immune response to HIV. Proceedings of the American Control Conference, Minneapolis, MN, 2006.
15. Wodarz D, Nowak M,. Specific therapy regimes could lead to long-term immunological control of HIV. Proceedings of the National Academy of Sciences 1999; 96: 14464-14469. (Pubitemid 30000673)
16. Adams BM, Banks HT, Davidian M, Rosenberg ES,. Model fitting and prediction with HIV treatment interruption data. Bulletin of Mathematical Biology 2007; 69: 563-584. (Pubitemid 46327270)
17. David JA, Tran HT, Banks HT,. HIV model analysis and estimation implementation under optimal control based treatment strategies. International Journal of Pure and Applied Mathematics 2009; 57 (3): 357-392.
18. David JA,. Optimal control, estimation and shape design: analysis and applications. Ph.D. Thesis, North Carolina State University, 2007.
19. Callaway DS, Perelson AS,. HIV-1 infection and low steady state viral loads. Bulletin of Mathematical Biology 2002; 64 (1): 29-64.
20. Culshaw RV,. Review of HIV models: the role of the natural immune response and implications for treatment. Journal of Biological Systems 2004; 12 (2): 123-135. (Pubitemid 39415577)
21. Bonhoeffer S, Rembiszewski M, Ortiz GM, Nixon DF,. Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection. Acquired Immune Deficiency Syndromes 2000; 14: 2313-2322.
22. Adams BM,. Non-parametric parameter estimation and clinical data fitting with a model of HIV infection. Ph.D. Thesis, North Carolina State University, 2005.
23. Adams BM, Banks HT, Davidian M, Kwon HD, Tran HT, Wynne SN, Rosenberg ES,. HIV dynamics: modelling, data analysis and optimal treatment protocols. Journal of Computational and Applied Mathematics 2005; 184: 10-49. (Pubitemid 41100712)
24. Ito K, Kunisch K,. Asymptotic properties of receding horizon optimal control problems. SIAM Journal on Control and Optimization 2001; 40 (5): 1585-1610.
25. Kelley CT,. Iterative Methods for Optimization. SIAM: Philadelphia, PA, 1999.
26. Lewis F,. Optimal Estimation: With an Introduction to Stochastic Control. Wiley: New York, 1986.
27. Kalman RE,. A new approach to linear filtering and prediction problems. Transactions of the ASME-Journal of Basic Engineering 1960; 82 (Series D): 35-45.
28. Welch G, Bishop G,. An introduction to the Kalman filter. Technical Report TR95-041, Department of Computer Science, University of North Carolina, 2001.
29. Murphy DG, Ct L, Fauvel M, Ren P, Vincelette J,. Multicenter comparison of roche COBAS AMPLICOR MONITOR version 1.5, organon teknika nuclisens qt with extractor, and bayer quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 rna in plasma. Journal of Clinical Microbiology 39 (3): 4034-4041, 200.
30. Hagihara K, Yamane T, Aoyama Y, Nakamae H, Hino M,. Evaluation of an automated hematology analyzer (CELL-DYN 4000) for counting cd4 + t helper cells at low concentrations. Annals of Clinical and Laboratory Science 2005; 35: 31-36. (Pubitemid 40396598)